Provectus Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
PVCT Over the counter 2834 http://www.pvct.com 1.908 Stock Up +0.048

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Provectus Pharmaceuticals Inc

PV-10 Immune Mechanism Data to Be Presented at the American Association for Cancer Research Annual Meeting - Mar 6th, 2014 9:58 am
Provectus Pharmaceuticals, Inc. Melanoma Version of PV-10 Completes Phase 2 and is Prepping for BTD - Feb 27th, 2014 7:23 am
Biotech Breakthroughs Brings Powerful Cancer Testing and Drugs to Market - Feb 18th, 2014 5:00 am
Biotech Stock Mailbag: Cell Therapeutics and the Ariad Hostile React-o-Meter Meltdown - Jan 31st, 2014 4:00 am
Provectus Announces PV-10’s Assessment for Drug-Drug Interaction Potential is Subject of Article Published by Xenobiotica - Jan 28th, 2014 10:52 am
Fisking Provectus' Claims About PV-10's FDA Approval Path - Jan 24th, 2014 11:41 am
PROVECTUS BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits - Jan 24th, 2014 11:33 am
Provectus's PV-10 Path to Initial Approval in U.S. Now Clear Per FDA Meeting Minutes - Jan 24th, 2014 10:09 am
Provectus Still Won't Answer Key Questions About Skin Cancer Drug PV-10 - Jan 24th, 2014 9:49 am
The Obsolescence of Provectus' Skin Cancer Drug Means Current Speculative Run Ends Badly - Jan 23rd, 2014 9:26 am
Provectus Pharmaceuticals, Inc. Analyst Research Report - Jan 22nd, 2014 5:00 am
PROVECTUS BIOPHARMACEUTICALS, INC. Financials - Jan 18th, 2014 11:04 am
PROVECTUS BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events - Jan 15th, 2014 3:19 pm
BioCentury covers news of Provectus' Type C meeting with FDA - Jan 13th, 2014 6:51 am
3 Humongous Health-Care Stocks This Week - Dec 28th, 2013 6:04 am
PROVECTUS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits - Dec 18th, 2013 7:02 am
Provectus Type C Meeting With FDA Oncology Division Held December 16, 2013 - Dec 18th, 2013 6:56 am
Provectus Type C Meeting With FDA Oncology Division Held December 16, 2013 - Dec 18th, 2013 5:10 am
PROVECTUS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Stat - Dec 17th, 2013 1:35 pm
Provectus Announces Name Change to Provectus Biopharmaceuticals, Inc. and Reincorporates in Delaware - Dec 17th, 2013 7:01 am